The Lancet Respiratory Medicine in conversation with
En podkast av The Lancet Group
156 Episoder
-
Yves Lacasse on long-term oxygen therapy for COPD
Publisert: 31.7.2022 -
Rachael Evans on living with long COVID
Publisert: 26.7.2022 -
Daniel Munblit and Dale Needham on core outcomes post-COVID-19
Publisert: 15.6.2022 -
Daiana Stolz on antibiotic stewardship in pneumonia
Publisert: 24.5.2022 -
Ablo Wachinou on sleep disordered breathing in Benin
Publisert: 8.4.2022 -
Peter Openshaw and Felicity Liew on corticosteroids in the early in the treatment of COVID
Publisert: 7.4.2022 -
Dinh Bui on preterm birth and lung function deficits
Publisert: 18.2.2022 -
Ruvim Izĭckson on a joint flu and COVID-19 vaccine
Publisert: 31.1.2022 -
Wisia Wedzicha on a vaccine for COPD
Publisert: 11.1.2022 -
Eileen Rubin on patient-centered ARDS
Publisert: 30.12.2021 -
Daniel Altmann on COVID boosters
Publisert: 30.11.2021 -
Michael Kreuter on interstitial lung disease
Publisert: 6.9.2021 -
Bairbre McNicholas and Jie Li on awake prone positioning and COVID-19
Publisert: 20.8.2021 -
Charles Sprung and authors on end-of-life practices in ICUs globally
Publisert: 3.8.2021 -
Christopher Brightling on tezepelumab in patients with moderate-to-severe uncontrolled asthma
Publisert: 10.7.2021 -
Paul Verweij on COVID-19 associated aspergillosis
Publisert: 26.5.2021 -
Ignacio Rubio on COVID-19 pathophysiology and phenotypes
Publisert: 17.5.2021 -
Kiran Shekar on cytokine adsorption and severe COVID-19 pneumonia
Publisert: 14.5.2021 -
Fan Chung on chronic cough and long COVID
Publisert: 11.5.2021 -
Mepolizumab and the treatment of chronic rhinosinusitis
Publisert: 16.4.2021
Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COIVD outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.
